Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,098 public trials 1,231 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Active, Not Recruiting

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT03611868

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +33 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • Highlands Oncology Rogers, Arkansas, United States
  • UCLA Hematology & Oncology Clinic Los Angeles, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

NCT03235245

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • University Hospitals Copenhagen - Herlev Hospital - University Copenhagen Herlev, Denmark
  • Odense University Hospital Odense, Denmark
  • Helsinki University Central Hospital - Dept of Oncology Helsinki, Finland
  • Tampere University Hospital Tampere, Finland
View all 38 locations
View Trial Details
Active, Not Recruiting

A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition

NCT05061134

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Tampa, Florida, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

Parental Decision-Making for Children With Relapsed Neuroblastoma

NCT02282735

Conditions
Death, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Stanford/Packard's Children's Hospital Palo Alto, California, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions